From: Responses to fertility treatment among patients with cancer: a retrospective cohort study
Pre-therapy diagnosis | n (%) |
---|---|
Breast | 79 (53.7) |
Breast cancer typea | |
āEstrogen Receptor Positive | 64 (81.0) |
āEstrogen Receptor Negative | 15 (19.0) |
āInflammatory | 2 (2.5) |
āHER-2 Positive | 18 (22.8) |
BRCA statusb | |
āNegative | 51 (64.6) |
āBRCA-1 Positive | 7 (8.9) |
āBRCA-2 Positive | 6 (7.6) |
āBRCA-1 andāāā2 Positive | 0 (0.0) |
Gynecologic | 8 (5.4) |
āOvarian | 1 (0.7) |
āEndometrial | 4 (2.7) |
āCervical | 5 (3.4) |
Hematologic | 38 (25.9) |
āLeukemia | 11 (7.5) |
āHodgkinās lymphoma | 18 (12.2) |
āNon-Hodgkinās lymphoma | 1 (0.7) |
āMyelodysplasia | 2 (1.4) |
Gastrointestinal | 6 (4.1) |
Brain | 6 (4.1) |
Other | 11 (7.5) |
Total | 147c (100) |